Home › Bids
› Assay Validation of High Quality Markers for Clinical Studie
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Open182 days leftHealthcaregrant
Oct 15, 2024
Oct 14, 2026 12:00 AM
Healthcare
grant
AI Summary
This grant opportunity (PAR-25-075) from the NIH focuses on assay validation of high-quality markers for clinical studies in cancer. UH3 clinical trials are not allowed under this funding opportunity (CFDA 93.394).
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.